Methylene Blue (MB) is one of the oldest synthetic pharmaceutical compounds still in clinical use, first synthesized in 1876. Today, it is experiencing a renaissance as one of the most scientifically compelling nootropic and cognitive support compounds available.
At the cellular level, Methylene Blue functions as a mitochondrial electron carrier — inserting itself directly into the electron transport chain and supporting ATP synthesis at the most fundamental level of cellular biology.
Key mechanisms include:
Acts as an alternative electron donor in the mitochondrial ETC
Supports cytochrome c oxidase activity
Demonstrates antioxidant properties by reducing reactive oxygen species
Crosses the blood-brain barrier, supporting neurological energy
Clinical research has shown MB to be effective at very low doses, with pharmaceutical-grade purity being critical to safety and efficacy.
Idrak Pharma's Neuro-Blue formula uses pharmaceutical-grade Methylene Blue in a precision liquid drop format, engineered for maximum bioavailability and precise dosing.